Johnson & Johnson acquisitions hit close to $15bn
Due.com
April witnessed a flurry of high-profile acquisitions by Johnson & Johnson, the healthcare behemoth. These strategic moves, amounting to nearly $15 bn, spanned across the medical care and consumer healthcare sectors, further diversifying the company’s portfolio. The company has announced two major takeover deals involving Ambrx Biopharma, Inc. and Shockwave Medical across April. Johnson & […]
The post Johnson & Johnson acquisitions hit close to $15bn appeared first on Due.
NYSE:JNJNASDAQ:SWAV